To further characterize this resemblance, breakpoints in 70 NPC genomes were compared to breakpoints in 139 breast cancer genomes from high-risk women (BRCA1/BRCA2 mutation, familial concentration, or young age). The gene discussed is BRCA2; the disease is breast carcinoma.